University of California at Los Angeles

Los Angeles, California 90095-7306

12 studies enrolling now · 67 studies all time

What they study most

ASD, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Advance Care Planning, Advance Directives, Advanced Cancer, Advanced Tumors, Alzheimer's Disease, Anemia

Studies at this site

• Brain Health in Breast Cancer Survivors — Recruiting now
• A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease — Recruiting now
• Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms — Recruiting now
• Treatment With Endovascular Intervention for STroke Patients With Existing Disability — Recruiting now
• A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers — Recruiting now
• Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal) — Recruiting now
• Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study — Recruiting now
• Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment — Recruiting now
• A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations — Recruiting now
• Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells — Recruiting now
• Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers — Recruiting now
• Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity — Recruiting now
• Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations — Running, not enrolling
• Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC) — Running, not enrolling
• Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy — Running, not enrolling
• The HPV 9-10 Trial: Early Initiation of HPV Vaccination — Completed
• Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H) — Completed
• Focal Laser Ablation of Prostate Cancer — Completed
• Psychoeducation for Uveal Melanoma — Running, not enrolling
• Study of COPD Subgroups and Biomarkers — Running, not enrolling
• Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee — Completed
• Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer — Stopped early
• UC Health Care Planning Study — Completed
• Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas — Completed
• Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma — Stopped early
• Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A — Stopped early
• Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer — Completed
• Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis — Completed
• A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer Survivors — Withdrawn before enrolling
• International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation — Completed
• Ziprasidone in the Psychosis Prodrome — Completed
• Role of Children in Transmission of COVID-19 to Immunocompromised Patients — Stopped early
• Specialized Pacing for Patients With Congenital Heart Disease — Stopped early
• International EXPAND Lung Pivotal Trial — Completed
• Imaging of Coronary Plaques in Participants Treated With Evolocumab — Completed
• OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection — Completed
• Double Cord Versus Haploidentical (BMT CTN 1101) — Completed
• Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging — APPROVED_FOR_MARKETING
• FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma — Completed
• Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC) — Completed
• Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors — Completed
• A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT — Stopped early
• A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer — Stopped early
• Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies — Completed
• Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma — Completed
• A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q — Completed
• Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. — Completed
• Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes — Completed
• Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment. — Completed
• Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma — Completed